MCM7 is one of the subunits of MCM2-7 complex, which is essential to DNA replication licensing and the control of cell cycle progression. It has been demonstrated that MCM7 participates in mRNA transcription and DNA damage regulation as well. MCM7 gene is found to be over-expressed in multiple cancers, but there are few reports about its effect in leukemia. Recent studies have proven that MCM7 expression has a relationship with diagnosis and prognosis, which has led to their potential clinical application as a marker for cancer screening. RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. It is a valuable research tool, which is widely used in cell culture and living organisms as well as in medicine recent years. It is indicated that RNAi application for targeting functional carcinogenic molecules, tumor resistance to chemotherapy and radiotherapy is required in cancer treatment. Gene products knockdown by RNAi technology exerts anti-proliferative and pro-apoptotic effects upon cell culture systems, animal models and in clinical trials in the most studies. In the present study, we found that MCM7 highly expressed in K562 cells rather than that in normal neutrophils. Thus, lentivirus-mediated shRNA targeting MCM7 was used to suppress its endogenous expression in K562 cells and develop a novel therapeutic strategy for leukemia.
This is a preview of subscription content, log in to check access.
This study was funded by the Fundamental Research Funds for the Central Universities and Colleges and Universities in Jiangsu Province plans to graduate research and innovation 2014 (No. KYLX_0198); Key Medical Projects of Jiangsu Province (BL2014078).
Compliance with ethical standards
Conflict of interest
Ethics approval and consent to participate
All animal experiments were conducted in conformity with institutional guidelines for the care and use of laboratory animals, and protocols were approved by the National Science Council, Republic of China, and the Institutional Animal Care and Use Committee in Southeast University, China (NO. 2007-51).
Li JH, Wei Q, Liu T, et al. Phosphorylation of minichromosome maintenance protein 7(MCM7) by cyclin/cyclin-dependent kinase affects its function in cell cycle regulation. J Biol Chem. 2013;288:19715–25.CrossRefPubMedPubMedCentralGoogle Scholar
Dalton S, Whitbread L. Cell cycle-regulated nuclear import and export of Cdc47, a protein essential for initiation of DNA replication in budding yeast. Proc Natl Acad Sci USA. 1995;92:2514–8.CrossRefPubMedPubMedCentralGoogle Scholar
Chong JP, Thömmes P, Blow JJ. The role of MCM/P1 proteins in the licensing of DNA replication. Trends Biochem Sci. 1996;21:102–6.CrossRefPubMedGoogle Scholar
Lee JK, Hurwitz J. Processive DNA helicase activity of the minichromosome maintenance proteins 4, 6, and 7 complex requires forked DNA structures. Proc Natl Acad Sci USA. 2001;98:54–9.CrossRefPubMedPubMedCentralGoogle Scholar
Foltman M, Evrin C, De Piccoli G, et al. Eukaryotic replisome components cooperate to process histones during chromosome replication. Cell Reports. 2013;3:892–904.CrossRefPubMedGoogle Scholar
Lei M, Tye BK. Initiating DNA synthesis: from recruiting to activating the MCM complex. J Cell Sci. 2001;114:1447–54.PubMedGoogle Scholar
Tsuji T, Ficarro SB, Jiang W. Essential role of phosphorylation of MCM2 by Cdc7/Dbf4 in the initiation of DNA replication in mammalian cells. Mol Biol Cell. 2006;17:4459–72.CrossRefPubMedPubMedCentralGoogle Scholar
You Z, Ishimi Y, Masai H, et al. Roles of Mcm7 and Mcm4 subunits in the DNA helicase activity of the mouse Mcm4/6/7 complex. J Biol Chem. 2002;277:42471–9.CrossRefPubMedGoogle Scholar
Cortez D, Glick G, Elledge SJ. Minichromosome maintenance proteins are direct targets of the ATM and ATR checkpoint kinases. Proc Natl Acad Sci USA. 2004;101:10078–83.CrossRefPubMedPubMedCentralGoogle Scholar
Yang H, Lan P, Hou Z, et al. Histone deacetylase inhibitor SAHA epigenetically regulates miR-17-92 cluster and MCM7 to upregulate MICA expression in hepatoma. Br J Cancer. 2015;112:112–21.CrossRefPubMedGoogle Scholar
Ishibashi Y, Kinugasa T, Akagi Y, et al. Minichromosome maintenance protein 7 is a risk factor for recurrence in patients with Dukes C colorectal cancer. Anticancer Res. 2014;34:4569–75.PubMedGoogle Scholar
Hua C, Zhao G, Li Y, Bie L. Minichromosome Maintenance (MCM) Family as potential diagnostic and prognostic tumor markers for human gliomas. BMC Cancer. 2014;14:526.CrossRefPubMedPubMedCentralGoogle Scholar
Kang W, Tong JH, Chan AW, et al. MCM7 serves as a prognostic marker in diffuse-type gastric adenocarcinoma and siRNA-mediated knockdown suppresses its oncogenic function. Oncol Rep. 2014;31:2071–8.PubMedGoogle Scholar
Wu JZ, Lu P, Liu R, et al. Transcription regulation network analysis of MCF7 breast cancer cells exposed to estradiol. Asian Pac J Cancer Prev. 2012;13:3681–5.CrossRefPubMedGoogle Scholar
Lee KS, Yuan YL, Kuriyama R, et al. Plk is an M-phase-specific protein kinase and interacts with a kinesin-like protein, CHO1/MKLP-1. Mol Cell Biol. 1995;15:7143–51.CrossRefPubMedPubMedCentralGoogle Scholar
Simizu SOH. Mutations in the Plk gene lead to instability of Plk protein in human tumour cell lines. Nat Cell Biol. 2000;2:852–4.CrossRefPubMedGoogle Scholar
Smith MR, Wilson ML, Hamanaka R, et al. Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase. Biochem Biophys Res Commun. 1997;234:397–405.CrossRefPubMedGoogle Scholar
Ikezoe T, Yang J, Nishioka C, et al. A novel treatment strategy targeting polo-like kinase 1 in hematological malignancies. Leukemia. 2009;23:1564–76.CrossRefPubMedGoogle Scholar
Gilmartin AG, Bleam MR, Richter MC, et al. Distinct concentration-dependent effects of the polo-like kinase 1-specific inhibitor GSK461364A, including differential effect on apoptosis. Cancer Res. 2009;69:6969–77.CrossRefPubMedGoogle Scholar
Wang F, Zhang W, Guo L, et al. Gambogic acid suppresses hypoxia-induced hypoxia-inducible factor-1a/vascular endothelial growth factor expression via inhibiting phosphatidylinositol 3-kinase/Akt/mammalian target protein of rapamycin pathway in multiple myeloma cells. Cancer Sci. 2014;105:1063–70.CrossRefPubMedPubMedCentralGoogle Scholar